The company's principal activities are manufacturing and marketing of an advanced cardiology instrument control system for use in the cath lab that revolutionizes the treatment of coronary artery disease and arrhythmias by enabling important new therapeutic solutions and enhancing the efficiency and efficacy of existing interventional procedures. The company's systems and disposable devices are developed and marketed in the United States and Europe.
